DAVID GARNER: Open Payments
NPI 1285305011 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $253 |
| ABBVIE INC. | 3 | $65 |
| Lundbeck LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Tris Pharma Inc | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Dyanavel XR, SPRAVATO, Auvelity, TRINTELLIX, FANAPT.
Industry payments across OH — which companies pay providers there.
